Clinical Trial Update: Treatment of Malignant Tumors With NK Cell [Phase 1, Phase 2]

View source ↗

Summary

A two-phase (Phase 1/2) clinical trial investigating NK cell therapy for malignant tumors; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignancy

Drugs mentioned

• NK cell therapy

Snippet

Sponsor: Shenzhen University General Hospital | Conditions: Malignancy | Phase 1, Phase 2 | Status: UNKNOWN